News

Under the agreement, the investors will purchase an aggregate of 4 million shares of common stock at a purchase price of $5.00 per share. The net proceeds of

Eli Lilly vice president and general patent counsel Doug Norman said: "Lilly respects the intellectual property of others and does not believe the application for approval of its

The lawsuit covers some or all of US patent Nos. 5,061,703; 8,039,009; 8,168,209; 8,173,708; 8,283,379; 8,329,752; 8,362,085; and 8,598,233. Forest licenses the ‘703 patent, which expires in April

After the consolidation, the new division will be called the R&D division. The purposes of the reorganization are to advance Kyowa Hakko Kirin’s ‘category-based strategy’ and enhance the

HETLIOZ is claimed to be the first FDA approved medication for Non-24, a chronic, circadian rhythm disorder resulting from the misalignment of the endogenous master body clock to

Around 300 patients with glaucoma or ocular hypertension will be enrolled in the 28-day trial, who will compare two concentrations of PG324 to latanoprost and to AR-13324, all

The FDA has issued an action date of 15 September 2014 under the Prescription Drug User Fee Act (PDUFA). Budesonide is a high potency corticosteroid developed to reduce

The trial was carried out under a US Food and Drug Administration (FDA) IND (Investigational New Drug) protocol, and it met all primary and secondary endpoints. A total

The agreement is for both Gelclair, an FDA-approved bioadherent oral rinse gel for treating the painful symptoms of oral mucositis (OM), and Soltamox (tamoxifen citrate) oral liquid solution,